New Horizons in Stress Urinary Incontinence Treatment
Highlights from the American Urogynecologic Society 2003 Scientific Meeting
Activity Date: March 15 2004 — Activity Info: Volume 4, (3C)
 

GOAL
To provide urologists, obstetricians/gynecologists, and urogynecologists with the most recent developments regarding the nonsurgical treatment of stress urinary incontinence (SUI).

TARGET AUDIENCE
This activity is designed for urologists, obstetricians/gynecologists, and urogynecologists. No prerequisites required.

LEARNING OBJECTIVES
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity. At the conclusion of this activity, participants should be able to:

  • Discuss the pathophysiology of SUI.
  • Evaluate the process of SUI diagnosis in the office.
  • Review the role of neurotransmitters and the central nervous system in lower urinary tract function.
  • Evaluate present and future nonsurgical therapies for SUI.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

The estimated time to complete this educational activity: 2 hours.

Release date: March 15, 2004. Expiration date: March 15, 2006.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

This program is supported by an unrestricted educational grant from Eli Lilly and Company.

 
 
     
 
Home | Contact Us | View Account | Need Help?